Zobrazeno 1 - 10
of 46
pro vyhledávání: '"Carole A. Harris"'
Autor:
Cristina M. Caperchione, Madeleine English, Paul Sharp, Meera R. Agar, Jane L. Phillips, Winston Liauw, Carole A. Harris, Susan McCullough, Ruth Lilian
Publikováno v:
BMC Health Services Research, Vol 23, Iss 1, Pp 1-10 (2023)
Abstract Background The majority of cancer patients and cancer care clinicians-CCCs (e.g., oncologists) believe that exercise is an important adjunct therapy that should be embedded in standard practice. Yet, CCCs do not routinely discuss exercise wi
Externí odkaz:
https://doaj.org/article/0c7557b901794ac08f1902a750736cef
Autor:
Susanna B. Park, J.M. McCrary, Jasmine C. Menant, Carole A. Harris, David Goldstein, B.C. Forster, Terry Trinh, K. Au, K.S. van Schooten
Publikováno v:
Gait & Posture. 89:178-185
Background Chemotherapy-induced peripheral neuropathy (CIPN) is reported to affect up to 70 % of cancer survivors. Despite evidence that CIPN-related impairments often translate into balance and mobility deficits, the effects on stepping and quality
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::463fea76da1ae84add43b83e2bec5c6f
https://doi.org/10.1016/j.gaitpost.2021.07.010
https://doi.org/10.1016/j.gaitpost.2021.07.010
Autor:
Derrick Ho Wai Siu, Robert Sean O'Neill, Carole A Harris, Justine Wang, Luke Ardolino, Teesha Downton, Matthew Tong, Jun Hee Hong, Venessa Chin, Philip R Clingan, Morteza Aghmesheh, Hussein Soudy
Publikováno v:
Immunotherapy. 14(7)
Immune checkpoint inhibitors have been incorporated into the treatment of various malignancies. An increasing body of literature is reporting rare but potentially fatal adverse events associated with these agents. In this case series, the authors rep
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::1d1a6da22ab564a829288e9dd5bbb16b
https://pubmed.ncbi.nlm.nih.gov/35321560
https://pubmed.ncbi.nlm.nih.gov/35321560
Autor:
Cristina M. Caperchione, Sean Stolp, Jane L. Phillips, Meera Agar, Paul Sharp, Winston Liauw, Carole A. Harris, Susan McCullough, Ruth Lilian
Publikováno v:
Asia-Pacific journal of clinical oncologyREFERENCES. 18(6)
This study aimed to (1) explore the perceptions of people living with cancer about exercise in general and exercise as an adjunct form of cancer care, (2) explore their perceptions regarding exercise counselling needs and preferences, and (3) investi
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::fd56721e259c53fdaeba916e586327af
https://pubmed.ncbi.nlm.nih.gov/35098655
https://pubmed.ncbi.nlm.nih.gov/35098655
Autor:
Susan McCullough, Winston Liauw, Ruth Lilian, Paul Sharp, Carole A. Harris, Cristina M. Caperchione, Elizabeth Marin, Meera Agar, Jane Phillips
Publikováno v:
Patient education and counseling. 105(7)
Objective This study aimed to 1) understand factors impacting the implementation of exercise communication and referral, and 2) explore integrated clinical approaches to exercise communication and referral in cancer care. Methods Seven focus groups (
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::88e3e2d903a88fb3831f3b4d84f9bced
https://pubmed.ncbi.nlm.nih.gov/35120796
https://pubmed.ncbi.nlm.nih.gov/35120796
Autor:
Hussein Soudy, Morteza Aghmesheh, Carole A. Harris, Matthew Tong, Robert S O'Neill, Ho Wai Siu, JunHee Hong
Publikováno v:
Journal for ImmunoTherapy of Cancer, Vol 8, Iss Suppl 3 (2020)
Background The use of immune checkpoint inhibitors (ICIs) against programmed cell death protein -1 (PD-1), its ligand (PD-L1) and cytotoxic T- lymphocyte associated protein 4 (CTLA4) have been increasing. Immune induced myocarditis, myositis and myas
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::0ad42aef35a0c6bbd2f56cff131cad84
https://doaj.org/article/dd4c162b9c054ccfa3132adf1de9fc4a
https://doaj.org/article/dd4c162b9c054ccfa3132adf1de9fc4a
Publikováno v:
Cancers. 14:1406
Angiogenesis inhibitors have been adopted into the standard armamentarium of therapies for advanced-stage renal cell carcinomas (RCC), but more recently, combination regimens with immune checkpoint inhibitors have demonstrated better outcomes. Despit
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::8b44420b3496810e47f16c5df67b7f81
https://doi.org/10.3390/cancers14061406
https://doi.org/10.3390/cancers14061406
Autor:
J.M. McCrary, Jasmine C. Menant, Carole A. Harris, Terry Trinh, K.S. van Schooten, B.C. Forster, K. Au, Susanna B. Park, David Goldstein
Publikováno v:
Gait & Posture. 92:1
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::e335a15ec01bdf28e8c6180e85309632
https://doi.org/10.1016/j.gaitpost.2021.11.006
https://doi.org/10.1016/j.gaitpost.2021.11.006
Autor:
Andrew Weickhardt, Carole A. Harris, Laurence Eliot Miles Krieger, Jeffrey C. Goh, Anthony M. Joshua, Arun Azad, Andrew Schmidt
Publikováno v:
Asia-Pacific journal of clinical oncologyREFERENCES. 15
Vascular endothelial growth factor receptor tyrosine kinase inhibitors have provided an effective standard of care for the treatment of metastatic clear cell renal cell carcinoma (mRCC). Survival is prolonged with emergence of modern immuno-oncology
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::ab3311ece4fcad44b08a9840523471f1
https://pubmed.ncbi.nlm.nih.gov/31762165
https://pubmed.ncbi.nlm.nih.gov/31762165
Autor:
Anthony M. Joshua, Elizabeth Hovey, Jeffrey C. Goh, Craig Underhill, Emma Link, Craig Gedye, David Pook, Stephen Begbie, Francis Parnis, Laurence Eliot Miles Krieger, Michelle Frances Morris, Howard Gurney, Mathew George, New Zealand Urogenital, Tom Ferguson, Ian D. Davis, Prashanth Prithviraj, Ganessan Kichenadasse, Carole A. Harris, Michelle Harrison, Felicia Roncolato
Publikováno v:
Journal of Clinical Oncology. 39:4565-4565
4565 Background: Immunotherapy targeting PD1 is active across many cancers, but many people are failed by PD1 inhibition alone. UNISON (ANZUP 1602/NCT03177239) has previously reported the activity and outcomes of nivolumab monotherapy in people with
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::567830202f3797b10e7543c383e56e2c
https://doi.org/10.1200/jco.2021.39.15_suppl.4565
https://doi.org/10.1200/jco.2021.39.15_suppl.4565